- AddressHeart Research Institute
Dr. Mary Kavurma received her PhD (2003) from the Centre for Vascular Research, UNSW. In 2004, she undertook an NHMRC CJ Martin Fellowship at the University of Cambridge UK. Here she developed an interest in the survival actions of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis and CVD. Mary established her team upon returning back to UNSW in 2007. Recently she relocated to the Heart Research Institute (2013) where she heads the Vascular Complications Group. Her current research is addressing critical questions concerning the impact of TRAIL in obesity, diabetes, CVD and chronic kidney disease.